Diagnosis and treatment of psychogenic parkinsonism

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 12, 2011, Pages 1300-1303

  Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CARBIDOPA; CARBIDOPA PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT;

CLINICAL FEATURE; COGNITIVE THERAPY; DEPRESSION; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISABILITY; DISEASE COURSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GAIT DISORDER; HUMAN; HYPNOSIS; PARKINSON DISEASE; PARKINSONISM; PHYSIOTHERAPY; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOGENIC PARKINSONISM; PSYCHOTHERAPY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS; STUTTERING; WEAKNESS;

EID: 80855130613     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2011-300876     Document Type: Review

References (49)

1. Thomas M, Jankovic J. Psychogenic movement disorders. In: Fahn S, Lang A, Schapira A, eds. Movement disorders, 4th Edn. Saunders Elsevier, Philadelphia, 2010:630-50.
2. Gupta A, Lang AE. Psychogenic movement disorders. Curr Opin Neurol 2009;22:430-6.
3. Peckham EL, Hallett M. Psychogenic movement disorders. Neurol Clin 2009;27:801-19.
4. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008;79:368-76. (Pubitemid 351441488)
5. Lang AE, Koller WC, Fahn S. Psychogenic parkinsonism. Arch Neurol 1995;52:802-10.
6. Factor SA, Podskalny GD, Molho ES. Psychogenic movement disorders: frequency, clinical profile, and characteristics. J Neurol Neurosurg Psychiatry 1995;59:406-12.
7. Thomas M, Jankovic J. Psychogenic movement disorders: diagnosis and management. CNS Drugs 2004;18:437-52. (Pubitemid 38736856)
8. Hinson VK, Haren WB. Psychogenic movement disorders. Lancet Neurol 2006;5:695-700. (Pubitemid 44062419)
9. Morgan JC, Sethi KD. Psychogenic parkinsonism. In: Hallett M, Fahn S, Jankovic J, et al., eds. Psychogenic movement disorders: neurology and neuropsychiatry. Philadelphia: AAN Enterprises and Lippincott Williams and Wilkins, 2006:62-8.
10. Thomas M, Vuong KD, Jankovic J. Long-term prognosis of patients with psychogenic movement disorders. Parkinsonism Relat Disord 2006;12:382-7. (Pubitemid 44192611)
11. Fekete R, Jankovic J. Psychogenic chorea associated with family history of Huntington disease. Mov Disord 2010;25:503-4.
12. Williams DT, Ford B, Fahn S. Phenomenology and psychopathology related to psychogenic movement disorders. Adv Neurol 1995;65:231-57.
13. Jankovic J, Hunter C. Psychogenic parkinsonism. In: Hallett M, Cloninger CR, Fahn S, et al. Psychogenic movement disorders and other related conversion disorders. Cambridge: Cambridge University Press, 2012.
14. Booij J, Speelman JD, Horstink MW, et al. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med 2001;28:266-72.
15. Gaig C, Martí MJ, Tolosa E, et al. 123I-Ioflupane SPECT in the diagnosis of suspected psychogenic parkinsonism. Mov Disord 2006;21:1994-8. (Pubitemid 44848954)
16. Benaderette S, Zanotti Fregonara P, Apartis E, et al. Psychogenic parkinsonism: a combination of clinical, electrophysiological, and [(123)I]-FP-CIT SPECT scan explorations improves diagnostic accuracy. Mov Disord 2006;21:310-17.
17. Felicio AC, Godeiro-Junior C, Moriyama TS, et al. Degenerative parkinsonism in patients with psychogenic parkinsonism: a dopamine transporter imaging study. Clin Neurol Neurosurg 2010;112:282-5.
18. Hellmann MA, Melamed E, Steinmetz AP, et al. Unilateral lower limb rest tremor is not necessarily a presenting symptom of Parkinson's disease. Mov Disord 2010;25:924-7.
19. Kenney C, Diamond A, Mejia N, et al. Distinguishing psychogenic and essential tremor. J Neurol Sci 2007;263:94-9. (Pubitemid 350029842)
20. Criswell S, Sterling C, Swisher L, et al. Sensitivity and specificity of the finger tapping task for the detection of psychogenic movement disorders. Parkinsonism Relat Disord 2010;16:197-201.
21. Baik JS, Lang AE. Gait abnormalities in psychogenic movement disorders. Mov Disord 2007;22:395-9. (Pubitemid 46569698)
22. McKeon A, Ahlskog JE, Bower JH, et al. Psychogenic tremor: long term prognosis in patients with electrophysiologically-confirmed disease. Mov Disord 2009:24:72-6.
23. Benedetti F, Mayberg HS, Wager TD, et al. Neurobiological mechanisms of the placebo effect. J Neurosci 2005;25:10390-402. (Pubitemid 41628443)
24. Goetz CG, Wuu J, McDermott MP, et al. Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions. Mov Disord 2008;23:690-9.
25. Shamy MC. The treatment of psychogenic movement disorders with suggestion is ethically justified. Mov Disord 2010;25:260-4.
26. Tilburt JC, Curlin FA, Kaptchuk TJ, et al. Alternative medicine research in clinical practice: a US national survey. Arch Intern Med 2009;169:670-7.
27. Finniss DG, Kaptchuk TJ, Miller F, et al. Biological, clinical, and ethical advances of placebo effects. Lancet 2010;375:686-95.
28. Hunter AM, Ravikumar S, Cook IA, et al. Brain functional changes during placebo lead-in and changes in specific symptoms during pharmacotherapy for major depression. Acta Psychiatr Scand 2009;119:266-73.
29. de la Fuente-Fernandez R, Ruth TJ, Sossi V, et al. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 2001;293:1164-6. (Pubitemid 32758101)
30. de la Fuente-Fernandez R, Stoessl AJ. The biochemical bases of reward: implications for the placebo effect. Eval Health Prof 2002;25:387-98. (Pubitemid 36950485)
31. Zaghloul KA, Blanco JA, Weidemann CT, et al. Human substantia nigra neurons encode unexpected financial rewards. Science 2009;323:1496-9.
32. Graybiel AM. Habits, rituals, and the evaluative brain. Annu Rev Neurosci 2008;31:359-87.
33. Flagel SB, Clark JJ, Robinson TE, et al. A selective role for dopamine in stimulus-reward learning. Nature 2010;469:53-7.
34. Lidstone SC, Schulzer M, Dinelle K, et al. Effects of expectation on placebo-induced dopamine release in Parkinson disease. Arch Gen Psychiatry 2010;67:857-65.
35. Kägi G, Bhatia KP, Tolosa E. The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry 2010;81:5-12.
36. Scherfler C, Schwarz J, Antonini A, et al. Role of DAT-SPECT in the diagnostic work up of parkinsonism. Mov Disord 2007;22:1229-38. (Pubitemid 47325028)
37. Schwingenschuh P, Ruge D, Edwards MJ, et al. Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study. Mov Disord 2010;25:560-9.
38. Bajaj NP, Gontu V, Birchall J, et al. Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study. J Neurol Neurosurg Psychiatry 2010;81:1223-8.
39. Marek M, Seibyl J, Eberly S. Clinical and imaging follow-up of SWEDD subjects in PRECEPT. Ann Neurol (in press).
40. Eckert T, Feigin A, Lewis DE, et al. Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging. Mov Disord 2007;22:167-73. (Pubitemid 46374756)
41. Voon V, Gallea C, Hattori N, et al. The involuntary nature of conversion disorder. Neurology 2010;74:223-8.
42. Vaillancourt DE, Spraker MB, Prodoehl J, et al. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 2009;72:1378-84.
43. Anderson KE, Gruber-Baldini AL, Vaughan CG, et al. Impact of psychogenic movement disorders versus Parkinson's on disability, quality of life, and psychopathology. Mov Disord 2007;22:2204-9.
44. Hallett M. Psychogenic movement disorders: a crisis for neurology. Curr Neurol Neurosci Rep 2006;6:269-71. (Pubitemid 44069966)
45. Ferrara J, Jankovic J. Psychogenic movement disorders in children. Mov Disord 2008;23:1875-81.
46. Schwingenschuh P, Pont-Sunyer C, Surtees R, et al. Psychogenic movement disorders in children: a report of 15 cases and a review of the literature. Mov Disord 2008;23:1882-8.
47. Jankovic J, Cloninger CR, Fahn S, et al. Therapeutic approaches to psychogenic movement disorders. In: Hallett M, Fahn S, Jankovic J, et al., eds. Psychogenic movement disorders: neurology and neuropsychiatry. Philadelphia: AAN Enterprises and Lippincott Williams and Wilkins, 2006:323-8.
48. Brashear A, Dobyns WB, de Carvalho Aguiar P, et al. The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene. Brain 2007;130:828-35. (Pubitemid 46410729)
49. Segawa M. Hereditary progressive dystonia with marked diurnal fluctuation. Brain Dev 2011;33:195-201.